Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma.

Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma. J Immunother Cancer. 2014; 2:11.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.